[HTML] nature.com

[HTML][HTML] Evaluating drug targets through human loss-of-function genetic variation

EV Minikel, KJ Karczewski, HC Martin, BB Cummings… - Nature, 2020 - nature.com
Naturally occurring human genetic variants that are predicted to inactivate protein-coding
genes provide an in vivo model of human gene inactivation that complements knockout …
被引用次数：150 相关文章

Evaluating drug targets through human loss-of-function genetic variation

EV Minikel, KJ Karczewski, HC Martin… - Nature, 2020 - econpapers.repec.org
Naturally occurring human genetic variants that are predicted to inactivate protein-coding
genes provide an in vivo model of human gene inactivation that complements knockout …

Evaluating drug targets through human loss-of-function genetic variation

EV Minikel, KJ Karczewski, HC Martin, BB Cummings… - 2020 - figshare.le.ac.uk
Naturally occurring human genetic variants that are predicted to inactivate protein-coding
genes provide an in vivo model of human gene inactivation that complements knockout …

[引用][C] Evaluating drug targets through human loss-of-function genetic variation

EV Minikel, KJ Karczewski, HC Martin, BB Cummings… - Nature, 2020 - mediatum.ub.tum.de
mediaTUM - Medien- und Publikationsserver mediaTUM Universitätsbibliothek Technische
Universität München Logo Benutzer: Gast Login de en Erweiterte Suche mediaTUM …

Evaluating drug targets through human loss-of-function genetic variation

EV Minikel, KJ Karczewski, HC Martin, BB Cummings… - NATURE, 2020 - qmro.qmul.ac.uk
Naturally occurring human genetic variants predicted to cause loss of function of protein-
coding genes provide an in vivo model of human gene inactivation that complements cell …

Evaluating drug targets through human loss-of-function genetic variation

Genome Aggregation Database Production Team… - …, 2020 - research.uni-luebeck.de
Naturally occurring human genetic variants that are predicted to inactivate protein-coding
genes provide an in vivo model of human gene inactivation that complements knockout …

Evaluating drug targets through human loss-of-function genetic variation

EV Minikel, KJ Karczewski, HC Martin, BB Cummings… - 2020 - trepo.tuni.fi
Naturally occurring human genetic variants that are predicted to inactivate protein-coding
genes provide an in vivo model of human gene inactivation that complements knockout …
[HTML] nih.gov

[HTML][HTML] Evaluating drug targets through human loss-of-function genetic variation

EV Minikel, KJ Karczewski, HC Martin, BB Cummings… - Nature, 2020 - ncbi.nlm.nih.gov
Naturally occurring human genetic variants that are predicted to inactivate protein-coding
genes provide an in vivo model of human gene inactivation that complements knockout …

Evaluating drug targets through human loss-of-function genetic variation

EV Minikel, KJ Karczewski, HC Martin, BB Cummings… - paper.sciencenet.cn
Naturally occurring human genetic variants that are predicted to inactivate protein-coding
genes provide an in vivo model of human gene inactivation that complements knockout …
[PDF] helsinki.fi

[PDF][PDF] Evaluating drug targets through human loss-of-function genetic variation

EV Minikel, KJ Karczewski, HC Martin, BB Cummings… - Nature, 2020 - helda.helsinki.fi
Naturally occurring human genetic variants that are predicted to inactivate protein-coding
genes provide an in vivo model of human gene inactivation that complements knockout …